News By Tag
News By Place
Follow on Google News
Innovative Learning Model to be Used to Address Global Hepatitis B Burden
According to the World Health Organization, approximately 300 million individuals globally live with chronic HBV infection, with 1.5 million receiving a new diagnosis each year. Prevalence varies by region, but the estimated prevalence of chronic HBV in countries such as the USA, China, and Thailand exceeds 90 million. Lack of symptoms in the early phases, coupled with the need for laboratory testing for disease confirmation, makes HBV diagnoses challenging;
Left untreated, HBV infection elevates the risk for long-term complications such as cirrhosis and hepatocellular carcinoma. In fact, the consequences of hepatitis B—cirrhosis and hepatocellular cancer—were responsible for 820,000 deaths worldwide in 2019.
More information on this program can be found at echo.dkbmed.com/
"The diagnosis and management of chronic HBV are complex matters, and many gaps in knowledge and practice remain unaddressed,"
With the 2022 ECHO HBV Workshop, DKBmed brings HBV education to clinicians practicing in China, Thailand, and the United States to treat patients with or at risk for HBV infection. Two ECHO learning groups are based in the United States, two ECHO learning groups are in China, and one ECHO group is in Thailand. The groups will be led by expert faculty from each of the respective countries. Each group will consist of 15 to 20 clinicians who will collaborate on Zoom for four weeks across four different activities. Topics will include:
Account Email Address Account Phone Number Disclaimer Report Abuse